[ET Net News Agency, 30 June 2025] EVEREST MED (01952) rose 10.1% to HK$63.
It hits an intra-day high of HK$63.1, hitting an 1-month high, and an intra-day low of
HK$57.3. The total shares traded was 7.89 million, with a value of HK$476.18m. The active
buy/sell ratio is 69:31, with net buying turnover of HK$172.44m. MERRILL LYNCH FE accounts
for greatest net responsive buying turnover of HK$8.66m, with volume weighted average
price of HK$61.151. CHINA INV INFO accounts for greatest net responsive selling turnover
of HK$37.79m, with volume weighted average price of HK$60.492. The stock has risen a
combined 30.3% over the past 7 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 63.000 % Chg +10.14%
High 63.100 Low 57.300
Shares Tr 7.89m Turnover 476.18m
10-D SMA 53.695 %H.V 83.871
20-D SMA 52.485 VWAP 60.349
50-D SMA 48.638 RSI14 70.909
----------------------------------
Status: Hitting an 1-month high, active buy/sell ratio is 69:31, with net buying turnover
of HK$172.44m, rising a combined 30.3% over the past 7 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
EVEREST MED (01952) 63.00 +10.14
SINO BIOPHARM (01177) 5.25 -0.94
3SBIO (01530) 23.25 +2.42
WUXI XDC (02268) 40.85 +2.38
ASCENTAGE-B (06855) 75.65 -2.32
SKB BIO-B (06990) 322.20 -1.47
ZAI LAB (09688) 27.60 Unchanged
AKESO (09926) 92.25 -0.27
INNOCARE (09969) 13.06 -1.80
REMEGEN (09995) 55.40 -0.27
---------------------------------------------
(ed)